Integrum Unveils Global Marketing Strategy at AOPA National Assembly
Integrum AB (INTEG B) unveiled its new global marketing strategy at the AOPA National Assembly in Orlando, introducing BondedMatrix™, a term describing the OPRA™ Implant System's unique capability to integrate soft tissue and bone. The strategy aims to better communicate the system's distinct advantages in bone-anchored prosthetics.
The OPRA™ Implant System, invented by Dr. Rickard Brånemark, has been refined since 1990 and has been used in over 1,000 implants worldwide. BondedMatrix™ specifically refers to the biologically integrated barrier connecting skin and bone at the penetration site, a unique feature achieved through OPRA's surgical technique and implant design.
Integrum AB (INTEG B) ha presentato la sua nuova strategia di marketing globale all'AOPA National Assembly di Orlando, introducendo BondedMatrix™, un termine che descrive la capacità unica del sistema di impianto OPRA™ di integrare tessuto molle e osso. La strategia punta a comunicare in modo più chiaro i vantaggi distintivi del sistema per le protesi ancorate all'osso.
Il sistema di impianto OPRA™, ideato dal Dr. Rickard Brånemark, è stato perfezionato dal 1990 ed è stato utilizzato in oltre 1.000 impianti a livello mondiale. BondedMatrix™ si riferisce in particolare alla barriera biologicamente integrata che collega pelle e osso nel sito di penetrazione, una caratteristica unica ottenuta grazie alla tecnica chirurgica e al design dell'impianto OPRA.
Integrum AB (INTEG B) presentó su nueva estrategia de marketing global en la AOPA National Assembly en Orlando, introduciendo BondedMatrix™, un término que describe la capacidad única del Sistema de Implante OPRA™ para integrar tejido blando y hueso. La estrategia busca comunicar mejor las ventajas distintivas del sistema en prótesis ancladas al hueso.
El Sistema de Implante OPRA™, inventado por el Dr. Rickard Brånemark, se ha perfeccionado desde 1990 y se ha utilizado en más de 1.000 implantes en todo el mundo. BondedMatrix™ se refiere específicamente a la barrera biológicamente integrada que conecta la piel y el hueso en el sitio de penetración, una característica única lograda gracias a la técnica quirúrgica y al diseño del implante OPRA.
Integrum AB (INTEG B)는 올랜도에서 열린 AOPA National Assembly에서 새로운 글로벌 마케팅 전략을 공개하며, 연조직과 골조직을 통합하는 OPRA™ 임플란트 시스템의 고유 기능을 설명하는 용어인 BondedMatrix™를 도입했습니다. 이 전략은 골고정 보철물 분야에서 시스템의 차별화된 장점을 보다 명확히 전달하는 것을 목표로 합니다.
OPRA™ 임플란트 시스템은 Rickard Brånemark 박사가 발명했으며 1990년 이후로 개선되어 전 세계에서 1,000건 이상의 임플란트에 사용되었습니다. BondedMatrix™는 침투 부위에서 피부와 뼈를 연결하는 생물학적으로 통합된 장벽을 구체적으로 지칭하며, 이는 OPRA의 수술 기법과 임플란트 설계로 달성된 고유한 특징입니다.
Integrum AB (INTEG B) a dévoilé sa nouvelle stratégie marketing mondiale lors de l'AOPA National Assembly à Orlando, introduisant BondedMatrix™, un terme décrivant la capacité unique du système d'implant OPRA™ à intégrer les tissus mous et l'os. La stratégie vise à mieux communiquer les avantages distinctifs du système pour les prothèses ancrées à l'os.
Le système d'implant OPRA™, inventé par le Dr Rickard Brånemark, a été perfectionné depuis 1990 et a été utilisé dans plus de 1 000 implants dans le monde. BondedMatrix™ se réfère spécifiquement à la barrière biologiquement intégrée reliant la peau et l'os au niveau du site de pénétration, une caractéristique unique obtenue grâce à la technique chirurgicale et au design de l'implant OPRA.
Integrum AB (INTEG B) stellte seine neue globale Marketingstrategie auf der AOPA National Assembly in Orlando vor und führte BondedMatrix™ ein, einen Begriff, der die einzigartige Fähigkeit des OPRA™-Implantatsystems beschreibt, Weichgewebe und Knochen zu integrieren. Die Strategie zielt darauf ab, die besonderen Vorteile des Systems für knochenverankerte Prothesen besser zu vermitteln.
Das OPRA™-Implantatsystem, erfunden von Dr. Rickard Brånemark, wurde seit 1990 verfeinert und in über 1.000 Implantaten weltweit eingesetzt. BondedMatrix™ bezeichnet speziell die biologisch integrierte Barriere, die Haut und Knochen an der Penetrationsstelle verbindet – ein einzigartiges Merkmal, das durch OPRAs chirurgische Technik und Implantatdesign erreicht wird.
- None.
- None.
MÖLNDAL,
BondedMatrix™ refers to the biologically integrated barrier that connects the skin and bone at the penetration site after healing — a result achievable by design with OPRA due to its unique surgical technique and implant design. While this capability has long been inherent to OPRA, the new designation provides a clearer way to communicate its benefits globally.
"This initiative is about creating a common language that makes OPRA™'s advantages more accessible to clinicians, prosthetists, and patients," said Jeffrey Zanni, President, Integrum Inc. "We are proud to introduce this globally, as defining BondedMatrix™ equips our partners with a powerful way to communicate why OPRA™ remains the most advanced solution in bone-anchored prosthetics."
Rickard Brånemark, MD, inventor of the OPRA Implant System and founder of Integrum, has refined this surgical technique with global partners since 1990. Over 1,000 implants have been placed worldwide, helping amputees regain mobility and independence.
"BondedMatrix™ is not a new feature, but a new way of defining a key component behind Integrum's decades of successful osseointegration."said Dr. Jason Souza, Director of the Advanced Amputation Program at Ohio State University and a leading expert in bone-anchored prosthetics. "Patients want a dependable and dry skin-implant interface - a BondedMatrix. The OPRA Implant System is the only one that can reliably deliver it. I'm excited that patients now have a way to ask for it."
Integrum are presenting this strategy at booth #931 during AOPA 2025, including live discussions and educational resources. On Thursday evening, the company will host an educational dinner meetingfeaturing Jason Souza, MD, Orthoplastic Surgeon at Ohio State University, highlighting patient outcomes and clinical experience with OPRA and BondedMatrix™.
For more information about BondedMatrix™ visit www.bondedmatrix.com.
CONTACT:
For more information, please contact:
Jeffrey Zanni, President US
Email: Jeff.Zanni@integrum.se
Phone: +1 617-839-1600
Jörgen Svanström, CFO
Phone: +46 (0) 7073 496 60,
Email: jorgen.svanstrom@integrum.se
Certified Adviser
The Company's Certified Adviser is DNB Carnegie Investment Bank AB.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Public/17531/4230014/a05f099446769910.pdf | 2025-09-04 BondedMatrix Press Release Final |
View original content:https://www.prnewswire.com/news-releases/integrum-unveils-global-marketing-strategy-at-aopa-national-assembly-302546736.html
SOURCE Integrum AB
FAQ
What is BondedMatrix™ in Integrum's OPRA™ Implant System?
How many OPRA™ implants has Integrum performed worldwide?
When and where did Integrum announce its new marketing strategy?
Who is presenting about OPRA and BondedMatrix™ at AOPA 2025?
Who invented the OPRA Implant System?
